Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].

Annales de biologie clinique - 1 Jan 2000

Deal C, Ajana F, Canva V, Mouton Y, Yazdanpanah Y, Wattré P, Bocket L

Abstract excerpt

Lamivudine (3TC) is a nucleoside analogue which inhibits replication of HIV and HBV and which is used in the treatment of chronic hepatitis B-infected patients with safety and efficacy. The activity of lamivudine was evaluated by the measurement of DNA-HBV concentration in plasma using a very sensitive assay (1,000 copies/mL) (Amplicor VHB Monitor. Roche). Ten patients chronically infected with hepatitis B (group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS-Related Opportunistic Infections
Share to Alanine Transaminase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-HIV Agents

Share to Drug Monitoring

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 12368144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].PMID 12368144Read ↗

[Treatment of chronic viral hepatitis B with lamivudine].Semantic proximity Read ↗

[Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].Semantic proximity Read ↗

[Determination of the lamivudine-resistant mutants of hepatitis B virus].Semantic proximity Read ↗

HBV mutations associated with lamivudine therapy.Semantic proximity Read ↗

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Lamivudine therapy for chronic hepatitis B].Semantic proximity Read ↗

[A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene].Semantic proximity Read ↗

Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

[Long-term use of lamivudine for treating chronic hepatitis B in the State of Mato Grosso].Semantic proximity Read ↗

[Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].Semantic proximity Read ↗

Experience with lamivudine against hepatitis B virus.Semantic proximity Read ↗

[Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.